(GLOV) Goldman Sachs ActiveBeta(R) - Overview
Etf: Equities, Developed Markets, Large Cap, Mid Cap
Dividends
| Dividend Yield | 1.82% |
| Yield on Cost 5y | 2.60% |
| Yield CAGR 5y | 14.93% |
| Payout Consistency | 98.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 8.61% |
| Relative Tail Risk | 5.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 8.66 |
| Character TTM | |
|---|---|
| Beta | 0.555 |
| Beta Downside | 0.560 |
| Drawdowns 3y | |
|---|---|
| Max DD | 9.97% |
| CAGR/Max DD | 1.69 |
Description: GLOV Goldman Sachs ActiveBeta(R) January 15, 2026
The Goldman Sachs ActiveBeta® World Low Vol Plus Equity ETF (BATS:GLOV) aims to track an index that targets large- and mid-cap equities from developed markets, including the United States, while maintaining a low-volatility tilt. At least 80 % of the fund’s assets are allocated to securities that are constituents of the underlying index, either directly, via depositary receipts, or through the underlying stocks of those receipts.
Key quantitative points (as of the most recent filing) include an expense ratio of 0.20 %, assets under management of roughly $550 million, and a 12-month annualized volatility of about 10 %-significantly lower than the S&P 500’s 15 % over the same period. The ETF’s sector weighting is tilted toward defensive industries such as consumer staples and health care, which tend to perform better in risk-off environments driven by higher interest rates or heightened geopolitical uncertainty.
For a deeper, data-driven comparison of GLOV’s risk-adjusted returns against other low-volatility strategies, you might explore ValueRay’s analytics platform to see how the fund’s metrics stack up.
What is the price of GLOV shares?
Over the past week, the price has changed by +0.99%, over one month by +2.42%, over three months by +5.30% and over the past year by +16.88%.
Is GLOV a buy, sell or hold?
What are the forecasts/targets for the GLOV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 68.3 | 15.2% |
GLOV Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.56b USD (1.56b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.56b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.56b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.96% (E(1.56b)/V(1.56b) * Re(7.96%) + (debt-free company))
Discount Rate = 7.96% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)